Strata Critical Medical, Inc.
Last · NASDAQ$4.28-0.17 (-3.82%)close · yahoo · 14h ago
Market cap$378.64M88.5M sh
P/E · TTM-15.3fwd — · eps -0.28 · loss
Beta2.43vs S&P 500
Div yield0.00%annual · TTM
52w range
$3.95$6.50
Volume825.0Ksession
| Revenue | $197.1M |
|---|---|
| Operating income | $-22.4M |
| Net income | $41.3M |
| Free cash flow | $-58.5M |
| Operating margin | -11.3% |
| Net margin | 21.0% |
| Return on equity | 14.8% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-03
- Operating Cf Burn
- Cash Conversion Weak
- Cash Runway Low
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Conversion Weak — Cash conversion (CFO/Rev) -24.8%
- Cash Runway Low — Cash runway ~0.6 years
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.01
Est. revenue
72.7M
Earnings transcripts
Press & signals
- GlobeNewswire
Strata Critical Medical Announces Second Quarter 2026 Results
- GlobeNewswire
Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform